ADCs for Breast Cancer: Clear Benefits, Manageable Risks

ADCs are rapidly changing the treatment landscape for patients with metastatic breast cancer, with the agents demonstrating improved efficacy and manageable risks.

Related Keywords

Memorial Sloan Kettering Cancer Center ,New York ,United States ,Seoul ,Soult Ukpyolsi ,South Korea ,Italy ,Milan ,Lombardia ,Republic Of Korea ,Bae Kim ,Giuseppe Curigliano ,Komal Jhaveri ,European Society For Medical Oncology ,University Of California San Francisco ,University Of Milan ,University Of Ulsan College Medicine ,European Society ,Medical Oncology ,Breast Cancer ,New York City ,Medscape Medical News ,Sung Bae Kim ,Ulsan College ,California San Francisco ,